The pharmaceutical index fell 2.13% this week to close at 1184951. From the stock price trend, the pharmaceutical index was hit out of the pit on Wednesday and fell 3.58%. The slight rise on Thursday and Friday did not reverse the decline of this week.
Among the top 10 pharmaceutical companies in terms of market value, the stocks with the top three weekly gains were dominated by cros. Among them, Pharmaron Beijing Co.Ltd(300759) , with a weekly increase of 7.86%, closed at 120.16 yuan / share on Friday, with a total market value of 95.428 billion yuan Hangzhou Tigermed Consulting Co.Ltd(300347) rose second, with a weekly increase of 5.38%. It closed at 105.35 yuan / share on Friday, with a total market value of 91.911 billion yuan. The market value ranked second to seventh; The third gainer was Wuxi Apptec Co.Ltd(603259) , with a weekly increase of 3.91%. It closed at 109.11 yuan / share on Friday, with a total market value of 322509 billion yuan, ranking first in the market value.
Among the top ten enterprises in market value, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) , the biggest decline this week, with a weekly decline of 7.93%, closed at 35.99 yuan / share on Friday, with a total market value of 60.129 billion yuan Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) went out of the “sky floor” this week. It rose by the limit on Thursday and fell by the limit on Friday. After hours data on Friday showed that the top three seats sold were Guotai Junan Securities Co.Ltd(601211) Shanghai Branch, China International Capital Corporation Limited(601995) Shanghai branch and Huaxin securities Ningbo Branch, with sales amounts of about 500 million yuan, 200 million yuan and 73 million yuan respectively.
On the news side, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) was “shelled” by Wang Sicong online on Thursday. Wang Sicong forwarded a message about “whether who recommends Lianhua Qingwen capsule to treat covid-19” on his microblog, and said that the CSRC should strictly investigate Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) . That night, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) Securities Department responded, “please point out the specific problems and sources of the news on the microblog, and we will answer the specific contents. You can’t ask questions at will because of the three words’ Wang Sicong ‘, investors please screen them.”
On that day, Wang Sicong’s shelling did not affect Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) share price, and Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) rose by the limit. However, on Friday, Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) was suddenly sold off. After opening in the afternoon, the limit fell, and the market value evaporated about 6.7 billion yuan in a single day.
It is worth noting that Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) has risen for six consecutive months, with a single month increase of 39% in March this year, and hit a record high of 43.12 yuan / share this week.
Jiangsu Hengrui Medicine Co.Ltd(600276) reaped good news this week. Jiangsu Hengrui Medicine Co.Ltd(600276) applied to FDA for a brief new drug of meglumine gadolinate injection has been approved. Brief new drug application is the application for generic drugs in the United States. The application for FDA review and approval means that the applicant can produce and sell the product in the U.S. market. Meglumine gadolinate injection is a gadolinium based intravenous contrast agent. In 2020, the global sales of gadolinate injection was about US $380 million. Up to now, Jiangsu Hengrui Medicine Co.Ltd(600276) has invested about 21.55 million yuan in R & D expenses for projects related to meglumine gadolinate injection.
In the pharmaceutical industry this week, the top three stocks were China Resources Double-Crane Pharmaceutical Co.Ltd(600062) , Dali Pharmaceutical Co.Ltd(603963) , Zhejiang Ausun Pharmaceutical Co.Ltd(603229) , with weekly increases of 42.66%, 20.37% and 16.38% respectively; The top three declines were Hainan Poly Pharm.Co.Ltd(300630) , Zhejiang Starry Pharmaceutical Co.Ltd(603520) , Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) , with declines of 32.98%, 19.79% and 17.55% respectively.
This week, the innovative drug index fell by 2.76%, the cro index fell by 0.89%, the traditional Chinese medicine index fell by 3.82%, the covid-19 pneumonia detection index rose by 0.25%, and the covid-19 specific drug index fell by 3.63%.
